AA
IDYA icon

AlphaCentric Advisors’s IDEAYA Biosciences IDYA Stock Holding History

AlphaCentric Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,000
Closed -$235K – 226
2021
Q1 		$235K Sell
10,000
-2,500
-20% -$48.3K 0.08% 85
2020
Q4 		$175K Buy
12,500
+11,000
+733% +$149K 0.07% 75
2020
Q3 		$19K Hold
1,500
– – 0.01% 148
2020
Q2 		$21K Buy
+1,500
New +$11.8K 0.01% 121

Other funds holding IDYA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

AlphaCentric Advisors's IDYA Position: Q2 2021 in Review

AlphaCentric Advisors sold out of IDEAYA Biosciences (IDYA) in Q2 2021, closing a stake of 10,000 shares — an estimated $235K sold.

AlphaCentric Advisors first reported a position in IDYA in Q2 2020 and held it in 4 quarters. The position peaked at $235K in Q1 2021. 84 funds tracked by Wall St. Rank hold IDYA as of Q2 2021.

  • AlphaCentric Advisors reported no remaining IDEAYA Biosciences position as of Q2 2021 after selling out during the quarter.
  • AlphaCentric Advisors sold 10,000 IDEAYA Biosciences shares in Q2 2021, an estimated $235K.
  • AlphaCentric Advisors first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 4 quarters.
  • AlphaCentric Advisors's IDEAYA Biosciences position peaked at $235K in Q1 2021.
  • 84 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2021.

Based on AlphaCentric Advisors's 13F filing for Q2 2021, filed 9 Mar 2022.